(Q43711065)

26 November 2017

Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. (English)

1 reference

26 November 2017

phase II clinical trial

0 references

phase I clinical trial

0 references

metastatic breast cancer

1 reference

14

1 reference

26 November 2017

Van Poznak C

1

1 reference

26 November 2017

Seidman AD

2

1 reference

26 November 2017

Reidenberg MM

3

1 reference

26 November 2017

Moasser MM

4

1 reference

26 November 2017

Sklarin N

5

1 reference

26 November 2017

Van Zee K

6

1 reference

26 November 2017

Borgen P

7

1 reference

26 November 2017

Gollub M

8

1 reference

26 November 2017

Bacotti D

9

1 reference

26 November 2017

Yao TJ

10

1 reference

26 November 2017

Bloch R

11

1 reference

26 November 2017

Ligueros M

12

1 reference

26 November 2017

Sonenberg M

13

1 reference

26 November 2017

Hudis C

15

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Breast Cancer Research and Treatment

26 November 2017

1 reference

26 November 2017

66

1 reference

26 November 2017

3

1 reference

26 November 2017

239-248

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1010686204736

26 November 2017

0 references

cites work

RB and the cell cycle: entrance or exit?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

Redundant cyclin overexpression and gene amplification in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

Cyclin D1 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

Gossypol treatment of recurrent adult malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

Antiproliferative activity of gossypol and gossypolone on human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

Antiproliferative effect of gossypol and its optical isomers on human reproductive cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

Inhibition of DNA polymerase alpha by gossypol

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

7 January 2021

Gossypol inhibits Ehrlich ascites tumor cell proliferation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

7 January 2021

Structural rearrangement of the retinoblastoma gene in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

7 January 2021

A preliminary clinical study of gossypol in advanced human cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

7 January 2021

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

7 January 2021

Cytotoxicity of gossypol enantiomers and its quinone metabolite gossypolone in melanoma cell lines.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

7 January 2021

Stereo-specific cytotoxic effects of gossypol enantiomers and gossypolone in tumour cell lines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686204736

7 January 2021

Identifiers

DOI

10.1023/A:1010686204736

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference